Bayer Crop Science IPO
Bayer Crop Science is a division of Bayer AG, a German multinational pharmaceutical and biotechnology company. As part of Bayer AG, it develops seeds, crop protection products, and digital farming solutions for agriculture.
What We Know
Bayer Crop Science is not a standalone public company but rather a division of Bayer AG, which has been publicly traded for decades on various exchanges including the Frankfurt Stock Exchange and as ADRs on U.S. markets. Bayer AG trades under ticker BAYRY on U.S. over-the-counter markets and BAY on German exchanges. Bayer significantly expanded its crop science operations through the acquisition of Monsanto in 2018 for $63 billion, making it one of the world's largest agricultural companies. The division operates as part of the larger Bayer conglomerate alongside pharmaceutical and consumer health divisions.
Frequently Asked Questions
Has Bayer Crop Science had an IPO?
Bayer Crop Science is part of Bayer AG, which has been publicly traded for many years. There was no separate IPO for the crop science division as it operates within the larger Bayer corporation.
When is the Bayer Crop Science IPO date?
Bayer Crop Science will not have its own IPO as it is a division of the already-public Bayer AG. There are no announced plans to spin off the crop science business.
How can I buy Bayer Crop Science stock?
You can buy Bayer AG stock, which includes the crop science division, through major brokerages. The stock trades as BAYRY on U.S. OTC markets or BAY on German exchanges.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts